Through various genetic toxicity tests, WestChina-Frontier’s experienced professional genetic toxicology study team has accumulated massive background data and positive maps from genetic toxicity tests, and has gained extensive practical experience.

The genetic toxicology study team can provide rapid and reliable preclinical screening of new drugs for potential mutagenicity/teratogenicity,

or a complete set of GLP-compliant tests in line with applicable NMPA/FDA/ICH/EPA/OECD guidelines in support of clients’ regulatory submission for their new drug application in countries/regions worldwide.